AU784361C - Progenitor cell preservation factors and related methods and products - Google Patents

Progenitor cell preservation factors and related methods and products

Info

Publication number
AU784361C
AU784361C AU24014/00A AU2401400A AU784361C AU 784361 C AU784361 C AU 784361C AU 24014/00 A AU24014/00 A AU 24014/00A AU 2401400 A AU2401400 A AU 2401400A AU 784361 C AU784361 C AU 784361C
Authority
AU
Australia
Prior art keywords
cells
fril
cell
family member
progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU24014/00A
Other languages
English (en)
Other versions
AU784361B2 (en
AU2401400A (en
Inventor
Maarten J. Chrispeels
M. Gabriella Colucci
Jeffrey G Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
ImClone LLC
Original Assignee
ImClone Systems Inc
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImClone Systems Inc, University of California Berkeley, University of California, San Diego filed Critical ImClone Systems Inc
Publication of AU2401400A publication Critical patent/AU2401400A/en
Publication of AU784361B2 publication Critical patent/AU784361B2/en
Application granted granted Critical
Publication of AU784361C publication Critical patent/AU784361C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AU24014/00A 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products Ceased AU784361C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/031307 WO2001049851A1 (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Publications (3)

Publication Number Publication Date
AU2401400A AU2401400A (en) 2001-07-16
AU784361B2 AU784361B2 (en) 2006-03-16
AU784361C true AU784361C (en) 2007-03-15

Family

ID=22274423

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24014/00A Ceased AU784361C (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Country Status (10)

Country Link
EP (1) EP1246919B1 (enExample)
JP (1) JP2003521900A (enExample)
CN (1) CN1406280A (enExample)
AT (1) ATE302848T1 (enExample)
AU (1) AU784361C (enExample)
CA (1) CA2395625A1 (enExample)
DE (1) DE69926920T2 (enExample)
ES (1) ES2249058T3 (enExample)
HK (1) HK1050027B (enExample)
WO (1) WO2001049851A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
JP4394350B2 (ja) 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
WO2002067973A1 (en) * 2001-02-27 2002-09-06 Phylogix Llc Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues
CN101415434A (zh) * 2003-11-12 2009-04-22 晨兴风险投资有限公司 用于治疗b细胞淋巴瘤和其它癌症的方法和组合物
WO2006110577A2 (en) * 2005-04-08 2006-10-19 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
EP2108043A4 (en) 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv NEW METHODS AND REAGENTS FOR THE PRODUCTION OF CELLS
US11083190B2 (en) 2007-06-29 2021-08-10 Makoto Funaki Soft gel systems in modulating stem cell development
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6247472B2 (ja) * 2013-08-06 2017-12-13 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
CN114262683B (zh) * 2022-03-01 2022-06-17 中国科学院动物研究所 一种表达vegfr3 d2多肽的细菌制剂及其构建方法和应用
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025457A1 (en) * 1996-12-09 1998-06-18 Imclone Systems Incorporated Composition and method for preserving progenitor cells
WO1998059038A1 (en) * 1997-06-24 1998-12-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998025457A1 (en) * 1996-12-09 1998-06-18 Imclone Systems Incorporated Composition and method for preserving progenitor cells
WO1998059038A1 (en) * 1997-06-24 1998-12-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Also Published As

Publication number Publication date
HK1050027B (en) 2006-04-13
EP1246919B1 (en) 2005-08-24
HK1050027A1 (en) 2003-06-06
WO2001049851A1 (en) 2001-07-12
AU784361B2 (en) 2006-03-16
CN1406280A (zh) 2003-03-26
DE69926920T2 (de) 2006-06-29
DE69926920D1 (de) 2005-09-29
JP2003521900A (ja) 2003-07-22
EP1246919A1 (en) 2002-10-09
ES2249058T3 (es) 2006-03-16
ATE302848T1 (de) 2005-09-15
CA2395625A1 (en) 2001-07-12
AU2401400A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
EP1246919B1 (en) Progenitor cell preservation factors and related methods and products
US6310195B1 (en) Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6280724B1 (en) Composition and method for preserving progenitor cells
US20040067583A1 (en) Methods for immortalizing cells
Caux et al. Sequential loss of CD34 and class II MHC antigens on purified cord blood hematopoietic progenitors cultured with IL-3: characterization of CD34-, HLA-DR+ cells
JP2022088551A (ja) 増殖造血幹細胞／前駆細胞集団の利用
JP2018095654A (ja) 造血コンパートメントの再構築及び自家再構築の増進
AU693032B2 (en) Methods for increasing hematopoietic cells
US6991794B1 (en) Progenitor cell preservation factors and methods for and products of their use
US20030022249A1 (en) Antigen-binding fragments that recognize a subset of dendritic cells and methods of use thereof
EP1584686A1 (en) Progenitor cell preservation factors and related methods and products
US7112653B2 (en) Composition and method for preserving progenitor cells
HK1084413A (en) Progenitor cell preservation factors and related methods and products
CN114174328B (zh) Gaba激动剂和拮抗剂影响造血干细胞和巨核系祖细胞的分化
JP2008521753A (ja) 副甲状腺ホルモン受容体の活性化並びに幹細胞及び前駆細胞の増殖
DE DK et al. NUKLEINSÄURE, WELCHE EINEN VON LEKTIN ABSTAMMENDEN FAKTOR ZUR PRÄSERVIERUNG VON PROGENITORZELLEN KODIERT ACIDE NUCLEIQUE CODANT UN FACTEUR DE CONSERVATION DE CELLULES PROGENITRICES DERIVE DE LA LECTINE
Sharkis STEM CELL PLASTICITY: WILL IT BE USEFUL TO REPAIR INJURY?
MXPA97009244A (en) Methods to increase hematopoyeti cells
HK1219051B (en) Methods of expanding myeloid cell populations and uses thereof

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE APPLICANTS NAME TO READ IMCLONE SYSTEMS INCORPORATED AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA